Roberto Salluzzo
Research Subjects
Roberto Salluzzo has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Corrado Romano
Section of Clinical Biochemistry and MedicalGenetics, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy, Italy
8 shared publications - Michele Salemi
Oasi Research Institute-IRCCS, 94018 Troina, Italy
8 shared publications Carmelo Romano
Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy
6 shared publications- Concetta Barone
IRCCS Associazione Oasi Maria SS, Institute for Research on Mental Retardation and Brain Aging, Troina, Italy
6 shared publications - Cataldo Scavuzzo
Oasi Institute for Research on Mental Retardation and Brain Aging
5 shared publications - Francesco Scillato
Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy
5 shared publications
Latest Publications
- 1 February 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (2) , 93-99
Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform
- 1 February 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (2) , 93-99
Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform
- 2 June 2015
- Vol. 61 (3) , 6-7
Letter to Editor: Cytochrome b gene expression in down syndrome subjects.
- 2 June 2015
- Vol. 61 (3) , 6-7
Letter to Editor: Cytochrome b gene expression in down syndrome subjects.
- Open Access
- 11 March 2015
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 10 (1)
LDOC1 expression in fibroblasts of patients with Down syndrome
Down syndrome (DS) is characterised by intellectual disability and is caused by trisomy 21. Apoptosis is a programmed cell death process and is involved in neurodegenerative diseases such as Alzheimer. People with DS can develop some traits of Alzheimer disease at an earlier age than subjects without trisomy 21. The leucine zipper, down regulated in cancer 1 (LDOC1) appears to be involved in the apoptotic pathways. The aim of the present work was to detect the presence of intracellular synthesis of LDOC1 protein and LDOC1 mRNA in fibroblast cultures from DS subjects. The western blot shows the presence of LDOC1 protein in fibroblasts of DS subjects but no evidence of LDOC1 protein in fibroblasts of normal subjects. LDOC1 gene mRNA expression is increased in fibroblasts from DS subjects compared to fibroblasts from normal subjects. The data obtained from this study strengthen the hypothesis that the over-expression of LDOC1 gene could play a role in determining the phenotype of individuals with DS but does not exclude that this results from apoptotic mechanisms
- 11 March 2015
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 10 (1)
Open AccessLDOC1 expression in fibroblasts of patients with Down syndrome
Down syndrome (DS) is characterised by intellectual disability and is caused by trisomy 21. Apoptosis is a programmed cell death process and is involved in neurodegenerative diseases such as Alzheimer. People with DS can develop some traits of Alzheimer disease at an earlier age than subjects without trisomy 21. The leucine zipper, down regulated in cancer 1 (LDOC1) appears to be involved in the apoptotic pathways. The aim of the present work was to detect the presence of intracellular synthesis of LDOC1 protein and LDOC1 mRNA in fibroblast cultures from DS subjects. The western blot shows the presence of LDOC1 protein in fibroblasts of DS subjects but no evidence of LDOC1 protein in fibroblasts of normal subjects. LDOC1 gene mRNA expression is increased in fibroblasts from DS subjects compared to fibroblasts from normal subjects. The data obtained from this study strengthen the hypothesis that the over-expression of LDOC1 gene could play a role in determining the phenotype of individuals with DS but does not exclude that this results from apoptotic mechanisms
- 27 August 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (11) , 2023-2025
Pericentrin expression in Down’s syndrome
- 27 August 2013
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (11) , 2023-2025
Pericentrin expression in Down’s syndrome
- 30 March 2012
- Published by Springer Nature in Journal of Genetics
- Vol. 93 (S1) , 18-23
Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects
- 30 March 2012
- Published by Springer Nature in Journal of Genetics
- Vol. 93 (S1) , 18-23
Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects
- 16 March 2012
- Published by Springer Nature in Journal of Genetics
- Vol. 91 (1) , 95-98
Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome
- 16 March 2012
- Published by Springer Nature in Journal of Genetics
- Vol. 91 (1) , 95-98
Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome
- 13 March 2012
- Vol. 91 (1) , e18-23
Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down's syndrome subjects.
- 13 March 2012
- Vol. 91 (1) , e18-23
Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down's syndrome subjects.
- 1 June 2007
- Published by Elsevier in Neuroscience Letters
- Vol. 419 (3) , 195-198
The CDC2 I-G-T haplotype associated with the APOE ɛ4 allele increases the risk of sporadic Alzheimer's disease in Sicily
- 1 June 2007
- Published by Elsevier in Neuroscience Letters
- Vol. 419 (3) , 195-198
The CDC2 I-G-T haplotype associated with the APOE ɛ4 allele increases the risk of sporadic Alzheimer's disease in Sicily
- 1 June 2007
- Published by SAGE Publications in Genetic Testing
- Vol. 11 (2) , 124-127
A New 6-bp SOX-3 Polyalanine Tract Deletion Does Not Segregate with Mental Retardation
SOX-3 is a transcription factor expressed throughout the developing central nervous system and is involved in maintenance of pluripotency in self-renewing stem cells, specification events, lineage progression, and terminal differentiation. An association between growth hormone deficiency, mental retardation, and Sox-3 mutations in humans was previously reported. The occurrence of abnormalities affecting the polyalanine tract of the Sox-3 gene was determined in a group of 77 unrelated mentally retarded patients without a definite genetic diagnosis and in 84 control subjects. A new SOX-3 polyalanine tract deletion was identified in a mentally impaired boy, in his mother (homozygous), and in 2 healthy brothers of the proband. This new mutation does not segregate with mental retardation.
- 1 June 2007
- Published by SAGE Publications in Genetic Testing
- Vol. 11 (2) , 124-127
A New 6-bp SOX-3 Polyalanine Tract Deletion Does Not Segregate with Mental Retardation
SOX-3 is a transcription factor expressed throughout the developing central nervous system and is involved in maintenance of pluripotency in self-renewing stem cells, specification events, lineage progression, and terminal differentiation. An association between growth hormone deficiency, mental retardation, and Sox-3 mutations in humans was previously reported. The occurrence of abnormalities affecting the polyalanine tract of the Sox-3 gene was determined in a group of 77 unrelated mentally retarded patients without a definite genetic diagnosis and in 84 control subjects. A new SOX-3 polyalanine tract deletion was identified in a mentally impaired boy, in his mother (homozygous), and in 2 healthy brothers of the proband. This new mutation does not segregate with mental retardation.
- 1 September 2000
- Published by Elsevier in Clinical Neurophysiology
- Vol. 111 (9) , 1632-1636
Does a peculiar EEG pattern exist also for FRAXE mental retardation?
- 1 September 2000
- Published by Elsevier in Clinical Neurophysiology
- Vol. 111 (9) , 1632-1636
Does a peculiar EEG pattern exist also for FRAXE mental retardation?